Trending News
News
News
Malaria Parasites Use Vortices To Get Mobile
Malaria parasites, that accumulate in mosquito salivary glands where space is very limited have been found to create vortices to allow collective movement.
News
"Good" Gut Microbes Keep Pathogens at Bay by Taking Their Energy Sources
Competition between "good" and pathogenic bacteria for energy sources confers protection against some strains of illness-causing bacteria.
News
Solid Tumors Use T Cells as a Shield Against Immune Attack
Researchers have discovered that solid tumors misuse a type of T cell, which protects them from the immune system.
News
Novel Pathogenic Bacterial Species Discovered in Onions
A novel species of bacteria has been discovered in onions in Texas, but the prevalence and distribution of the pathogen are still unknown.
News
Bacteria With Recording Functionality Created To Monitor Gut Health
Researchers have equipped gut bacteria with data loggers to monitor which genes are active in the bacteria. These microorganisms could one day offer a noninvasive means of diagnosing disease or assessing the impact of a diet on health.
News
Vaccine for Mosquito-Borne Virus Found To Be Safe and Well Tolerated
A phase one clinical trial of a new vaccine for three mosquito-borne encephalitis viruses has shown the vaccine to be safe and capable of inducing an antibody response.
News
Targeted Drug Delivery Systems Designed From Llama Nanobodies
Researchers at Johns Hopkins Medicine have designed nanobodies from llama antibodies that could be used to deliver medicines to human muscle cells.
News
Can Sour Cream's Health Benefits Be Increased by Adding Pickles?
A new study determined that adding pickled cucumbers to sour cream can improve its antioxidant properties and enhance its health-promoting activities.
News
New CRISPR-Cas9 Carrier Makes Genome Editing More Efficient
A novel carrier for delivering CRISPR-Cas9 complexes into the cell nucleus has been developed using polyrotaxane to make genome editing more efficient.
News
Volunteers Dosed in Clinical Trials of “RBD” COVID-19 Vaccines
The first volunteers have been administered with the first dose of a new vaccine that focuses on the immune response to the receptor binding domain (RBD) of the SARS-CoV-2 spike protein.
Advertisement